133 related articles for article (PubMed ID: 3900664)
21. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
Oishi S; Sato T
Cancer; 1988 Mar; 61(6):1167-70. PubMed ID: 3342373
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
23. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
24. Neuron-specific enolase-producing leiomyosarcoma of the mesentery.
Fukunaga M
APMIS; 2004 Feb; 112(2):105-8. PubMed ID: 15056226
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of malignant melanoma.
Hirano T
Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
[No Abstract] [Full Text] [Related]
27. Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker.
Grauer A; Raue F; Rix E; Tschahargane C; Ziegler R
J Cancer Res Clin Oncol; 1987; 113(6):599-602. PubMed ID: 3316243
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
[TBL] [Abstract][Full Text] [Related]
29. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Mjønes P; Sagatun L; Nordrum IS; Waldum HL
J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
[TBL] [Abstract][Full Text] [Related]
30. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Suh KJ; Keam B; Kim M; Park YS; Kim TM; Jeon YK; Kim DW; Chung DH; Kim YW; Heo DS
Clin Lung Cancer; 2016 Jul; 17(4):245-252.e1. PubMed ID: 26719155
[TBL] [Abstract][Full Text] [Related]
31. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
32. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
[TBL] [Abstract][Full Text] [Related]
33. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
34. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
[TBL] [Abstract][Full Text] [Related]
35. Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.
Nakasuka H; Okada S; Okusaka T; Ishii H; Ikeda M; Ito R; Kosakamoto H; Yoshimori M; Nakanishi Y; Sakamoto M
Jpn J Clin Oncol; 1998 Jun; 28(6):401-4. PubMed ID: 9730157
[TBL] [Abstract][Full Text] [Related]
36. Clinical biochemistry of neuron specific enolase.
Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
[TBL] [Abstract][Full Text] [Related]
37. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemical study of a trabecular carcinoma of the skin (Merkel cell tumor). Case report.
Carlei F; Lomanto D; Chimenti S; Pranteda G; Castagna G; Lezoche E; Mariani P; D'Alessandro MD; Gendel SE; Speranza V
Ital J Surg Sci; 1986; 16(1):55-9. PubMed ID: 2424864
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
Asa SL; Ryan N; Kovacs K; Singer W; Marangos PJ
Arch Pathol Lab Med; 1984 Jan; 108(1):40-3. PubMed ID: 6362613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
